Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC

Documenti analoghi

• Comparison of clinical and MRI features of brain metastases between ALK+ and ALK‐ NSCLC
  di: Xiaolu Ren, et al.
  Pubblicazione: (2024)
• High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the PI3K/Akt pathway through targeted inhibition of TPX2 in endometrial cancer
  di: Mei Yang, et al.
  Pubblicazione: (2024)
• Arteannuin B Inhibits NSCLC Cells via Regulating miR ‐194‐3p/ CLDN2 Axis
  di: Ting‐Sha He, et al.
  Pubblicazione: (2026)
• The association of genomic alterations with PD‐L1 expression in Chinese patients with EGFR/ALK wild‐type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy
  di: Fangfang Liu, et al.
  Pubblicazione: (2024)
• RETRACTED: LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression
  di: Jinhai Tian, et al.
  Pubblicazione: (2024)